Atlas Trials

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Clinical trial NCT00036088 · COMPLETED

Trial details

NCT number
NCT00036088
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2001-08-01
Enrollment
530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.